Further experiments showed that the use of DOT1L inhibitors in multiple myeloma can induce cell cycle arrest and apoptosis, and can strongly inhibit cell proliferation in vitro (Ishiguro et al., 2019). The gene discussed is DOT1L; the disease is AL amyloidosis.